Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020

By afschroeder • March 7, 2026

Donohue J, Wang B, Tang L, Kim JY, Junker S, Cole E, Chang CH, Roberts E, Wilson JD, Essien U, Gifford K, Hammerslag L, Talbert J, Ahrens K, Idala D, Mohamoud S, Clark S, Austin A, Ware O, Tossone K, Mack A, Fry C, Gordon AJ, Barnes A, Marks S, Cunningham P, Allen L, Burns M, Kennedy S. Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020. J Subst Use Addict Treat. 2026 Mar 4:209924. doi: 10.1016/j.josat.2026.209924. Epub ahead of print. PMID: 41791553.

Tags: buprenorphine, General Internal Medicine, medicaid, Medication for opioid-use disorder, methadone, naltrexone, Overdose, Publications, Racial/ethnic differences, Veterans Administration

Editorial Comment

Melamed S, Waterman B, Bergman J. Editorial Comment. Urol Pract. 2026 Apr 29:101097UPJ0000000000001018. doi: 10.1097/UPJ.0000000000001018. Epub ahead of print. PMID: 42047621.

Initiation Setting and Persistence of Medications Affecting Cognition in Older Adults

Ly DP, Yang AW, Leng M, Sarkisian C, Damberg CL, Mafi JN. Initiation Setting and Persistence of Medications Affecting Cognition in Older Adults. JAMA Netw[...]

Primary Care Challenges With Care Coordination

Chang ET. Primary Care Challenges With Care Coordination. JAMA Netw Open. 2026 Apr 1;9(4):e269120. doi: 10.1001/jamanetworkopen.2026.9120. PMID: 42048085.